Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2026-01-01 @ 3:04 PM
Study NCT ID:
NCT05228158
Status:
RECRUITING
Last Update Posted:
2024-12-27
First Post:
2022-01-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan
Sponsor:
Eisai Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-16
Start Date Type:
ACTUAL
Primary Completion Date:
2028-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-01-27
First Submit QC Date:
None
Study First Post Date:
2022-02-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-20
Last Update Post Date:
2024-12-27
Last Update Post Date Type:
ACTUAL